✓
Open
29 Sep to 4 Oct, 2017
✓
Close
29 Sep to 4 Oct, 2017
3
Allotment
—
✓
Listing
Thu, Oct 12, 2017
Price Band
₹85 per share
Issue Size
22,96,000 shares (agg. up to ₹20 Cr)
Lot Size
1,600 Shares
Listing Date
Thu, Oct 12, 2017
✦ AI Insight
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 18.76x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2017 | 31 Mar 2016 | 31 Mar 2015 |
|---|---|---|---|
| Assets | 24.54 | 15.20 | 8.01 |
| Total Income | 41.68 | 26.39 | 0.26 |
| Profit After Tax | 5.18 | 1.13 | 0.11 |
| NET Worth | 7.38 | 2.20 | 1.07 |
| Reserves and Surplus | 6.37 | 1.19 | 0.06 |
| Total Borrowing | 7.52 | 7.75 | 4.37 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Shree Ganesh Remedies Ltd. | SME | ₹8.55 Cr | ₹36 | null | ₹33.00 | -8.33% | ₹648.20 (-0.39%) |
| ANG Lifesciences India Ltd. | SME | ₹12.01 Cr | ₹80 | null | ₹96.00 | +20.00% | ₹33.22 (-2.32%) |
| Vaishali Pharma Ltd. | SME | ₹14.23 Cr | ₹72 | null | ₹70.35 | -2.29% | ₹7.84 (-0.51%) |
| Zota Health Care Ltd. | SME | ₹58.50 Cr | ₹125 | null | ₹125.60 | +0.48% | ₹1,349.70 (-1.48%) |
| Sakar Healthcare Ltd. | SME | ₹14.81 Cr | ₹50 | null | ₹52.15 | +4.30% | ₹877.70 (-2.15%) |
| Eris Lifesciences Ltd. | Mainboard | ₹1,740.49 Cr | ₹603 | null | ₹601.50 | -0.25% | ₹1,455.40 (-2.44%) |
| Laurus Labs Ltd. | Mainboard | ₹1,330.51 Cr | ₹428 | null | ₹480.40 | +12.24% | ₹1,529.80 (-1.79%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Purchase of new plant and machinery and upgradtion of the existing plant and machinery | 7.42 |
| 2 | Civil Construction work at existing manufacturing unit. | 1.28 |
| 3 | To obtain registration of European Union GMP & Pharmaceutical Inspection Co-operation Scheme | 0.79 |
| 4 | Working Capital | 2.95 |
| 5 | General Corporate Purpose | 4.10 |
About Beta Drugs IPO
Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases.Beta Drugs Limited is a part of Adley Group, which was founded in the year 1985. Company's manufacturing unit is located at Solan, Himachal Pradesh. Company Strengths:1. Focus on oncology segment. Manufacture over 50 products in this segment.2. 18 product registrations in various countries. Company is in-process of making additional 12 applications for product registration in various countries.+ Read More
Contact Details
Beta Drugs Ltd. AddressVillage, NandpurBaddi, Himachal Pradesh, 1741001795-236196info@betadrugslimited.comVisit Website